We performed a comprehensive pathological review of over 300 RPs from a prospectively collected multi-institutional cohort and mapped and graded each tumor focus based on H&E examination and molecular classifiers (ERG rearrangement, SPINK1 overexpression, PTEN deletion, and SPOP mutation). The gene discussed is ERG; the disease is neoplasm.